Abstract: A switch device includes a common node that is connected to end nodes, such as that of computer interface ports. The switch device includes several switch circuits that can be connected in series to form a switch path between the common node and an end node. A switch circuit can include a main switch, such as a transistor that can be configured to withstand a positive or negative voltage surge by automatically changing the connection of its gate.

Abstract: The present invention is directed to fused heteroaryl derivative compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

Abstract: A switch device includes a common node that is connected to end nodes, such as that of computer interface ports. The switch device includes several switch circuits that can be connected in series to form a switch path between the common node and an end node. A switch circuit can include a main switch, such as a transistor that can be configured to withstand a positive or negative voltage surge by automatically changing the connection of its gate.

Abstract: The present invention is directed to piperidine oxadiazole and thiadiazole orexin compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

Abstract: A switch device includes a common node that is connected to end nodes, such as that of computer interface ports. The switch device includes several switch circuits that can be connected in series to form a switch path between the common node and an end node. A switch circuit can include a main switch, such as a transistor that can be configured to withstand a positive or negative voltage surge by automatically changing the connection of its bulk.

Abstract: The present invention is directed to fused heteroaryl derivative compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

Abstract: According to an implementation, an audio switch circuit includes an audio switch configured to selectively couple an input node to an output node to transfer an audio signal across the audio switch. The audio switch has an on-resistance in response to the input node being coupled to the output node. The on-resistance of the audio switch changes by a first value in response to an input voltage of the audio signal increasing from a first level to a second level. The audio switch circuit includes an on-resistance compensation circuit configured to have an on-resistance that changes by a second value in response to the input voltage of the audio signal increasing from the first level to the second level. The on-resistance compensation circuit is coupled to the audio switch such that the second value at least partially offsets the first value.

Abstract: The present invention is directed to piperidine isoxazole and isothiazole orexin compounds which are antagonists of orexin receptors. Such compounds are of the general structural formula I: wherein the variables are defined herein. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

Abstract: The present invention is directed to pyrazole, triazole and tetrazole compounds which are antagonists of orexin receptors. Such compounds are of the general structural formula I: The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

Abstract: The present invention is directed to oxazole compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the oxazole compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

Abstract: The present invention is directed to piperidine isoxazole and isothiazole orexin compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

Abstract: The present invention is directed to pyrazole, triazole and tetrazole compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the pyrazole, triazole, and tetrazole compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

Abstract: The present invention is directed to piperidine oxadiazole and thiadiazole orexin compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

Abstract: The present invention is directed to thiazole compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the thiazole compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

Abstract: The present invention is directed to thiazole compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the thiazole compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

Abstract: The present invention is directed to oxazole compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the oxazole compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

Abstract: A switch device includes a common node that is connected to end nodes, such as that of computer interface ports. The switch device includes several switch circuits that can be connected in series to form a switch path between the common node and an end node. A switch circuit can include a main switch, such as a transistor that can be configured to withstand a positive or negative voltage surge by automatically changing the connection of its gate.

Abstract: A system and method are disclosed for determining the root cause of non-deterministic tests. An exemplary system may receive a non-deterministic test and run the non-deterministic test with call trace collection enabled. For each trace, the system may determine whether the trace was associated with a passing or failing test. Each trace may be labeled according to the trace's association. Then, dynamic call trees may be constructed, one for the traces associated with passing tests and one for traces associated with failing tests. The dynamic call trees may be compared to determine subtree patterns that occur in one tree, but not the other. The subtree patterns may then be ranked based on the number of times the subtrees occur in the traces in order to determine the root cause of the non-deterministic test.

Abstract: The present invention discloses a load driving circuit, comprising a voltage differential generation circuit and a common mode voltage generation circuit; wherein the voltage differential generation circuit is configured to generate a driving voltage for driving a load; and the common mode voltage generation circuit is configured to: when the voltage differential generation circuit generates the driving voltage for driving the load, regulate the voltages output by a first output terminal and a second output terminal of the voltage differential generation circuit to the same voltage value. The present invention also provides a load driving method and application devices thereof. With the technical solutions according to the present invention, a central value of a voltage output by the first output terminal and a voltage output by the second output terminal of the voltage differential generation circuit is effectively regulated.

Abstract: Disclosed is an overcurrent protection method and circuit and an integrated circuit. The overcurrent protection circuit includes an output circuit, an overcurrent sampling circuit and an overcurrent protection loop circuit. The overcurrent sampling circuit is configured to perform overcurrent sampling on the output circuit, and to pass the sampled current to the overcurrent protection loop circuit, and the overcurrent protection loop circuit is configured to perform direct current level shifting on the sampled current to result in a control current, and to provide a negative feedback to the output current of the output circuit based on the control current.